The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq).
 
Andrew B Katims
Employment - Abbott Laboratories (I)
Stock and Other Ownership Interests - Exelixis
 
Fengshen Kuo
Stock and Other Ownership Interests - 10x Genomics; Cigna; Cigna (I); General Electric (I); Merck; Pfizer; Sanofi (I); Viatris
 
Peter Reisz
No Relationships to Disclose
 
Andrew Tracey
No Relationships to Disclose
 
Jasmine Thomas
No Relationships to Disclose
 
Wesley Yip
Consulting or Advisory Role - Gilead Sciences; SAI MedPartners
 
Taha Merghoub
Stock and Other Ownership Interests - Imvaq therapeutics
Honoraria - Leap Therapeutics; Pfizer
Consulting or Advisory Role - ImmunoGenesis; Immunos Therapeutics
Research Funding - BMS; Surface Oncology
Patents, Royalties, Other Intellectual Property - inventor on patent applications related to work on oncolytic viral therapy, alphavirus-based vaccines, neo-antigen modeling, CD40, GITR, OX40, PD-1 and CTLA-4.
 
Bernard H. Bochner
Consulting or Advisory Role - Olympus
 
Eugene J. Pietzak
Honoraria - UpToDate
Consulting or Advisory Role - Chugai Pharma; Janssen; Merck; QED Therapeutics; Urogen pharma
Research Funding - Janssen
 
David B. Solit
Stock and Other Ownership Interests - Fore Biotherapeutics; Pyramid Biosciences; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Fog Therapeutics; Fore Biotherapeutics; Pfizer; Scorpion Therapeutics; Vividion Therapeutics
 
A. Ari Hakimi
Consulting or Advisory Role - Merck
 
Kwanghee Kim
Stock and Other Ownership Interests - Arvinas
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
(OPTIONAL) Uncompensated Relationships - AngioDynamics; Steba Biotech